244 related articles for article (PubMed ID: 16079640)
1. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategies in endothelial dysfunction: physical exercise versus pharmacological therapy.
Gielen S; Hambrecht R
Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):318-20. PubMed ID: 16079637
[No Abstract] [Full Text] [Related]
3. Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.
Ling MC; Ruddy TD; deKemp RA; Ukkonen H; Duchesne L; Higginson L; Williams KA; McPherson R; Beanlands R
Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976803
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.
Houghton JL; Pearson TA; Reed RG; Torosoff MT; Henches NL; Kuhner PA; Philbin EF
Chest; 2000 Sep; 118(3):756-60. PubMed ID: 10988199
[TBL] [Abstract][Full Text] [Related]
5. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.
Quyyumi AA
J Am Coll Cardiol; 1998 Oct; 32(4):904-11. PubMed ID: 9768710
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
Sebestjen M; Boh M; Keber I
Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
[TBL] [Abstract][Full Text] [Related]
7. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
[TBL] [Abstract][Full Text] [Related]
8. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia.
Grigore L; Raselli S; Garlaschelli K; Redaelli L; Norata GD; Pirillo A; Catapano AL
Eur J Clin Pharmacol; 2013 Mar; 69(3):341-6. PubMed ID: 22777149
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
Settergren M; Böhm F; Rydén L; Pernow J
Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
[TBL] [Abstract][Full Text] [Related]
13. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
Hamilton SJ; Chew GT; Davis TM; Watts GF
Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
16. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease.
Sixt S; Rastan A; Desch S; Sonnabend M; Schmidt A; Schuler G; Niebauer J
Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):473-8. PubMed ID: 18677174
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).
Masumoto A; Hirooka Y; Hironaga K; Eshima K; Setoguchi S; Egashira K; Takeshita A
Am J Cardiol; 2001 Dec; 88(11):1291-4. PubMed ID: 11728357
[No Abstract] [Full Text] [Related]
18. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
20. Beyond lipids - the role of the endothelium in coronary artery disease.
Aengevaeren WR
Atherosclerosis; 1999 Sep; 147 Suppl 1():S11-6. PubMed ID: 10575057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
